NDC 74695-823

Vivjoa 150 mg capsule

On the label: Mycovia Pharmaceuticals, Inc..

Germany: 1United States: 1Canada: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Dynamit Nobel GmbH Explosivstoff- und SystemtechnikLeverkusen, GermanyMakes the active ingredient Problems found, fixed voluntarilySep 1, 2023 · 5 inspections
Evonik CorporationLafayette, IN, United StatesMakes the active ingredient No problems foundSep 11, 2025 · 7 inspections
Patheon Inc.Whitby, CanadaMakes it Problems found, fixed voluntarilyFeb 17, 2023 · 8 inspections
BioChem Labor für biologische und chemische Analytik GmbHKarlsruhe, GermanyTests it No problems foundMar 23, 2022 · 4 inspections
Chemcon GmbHFreiburg im Breisgau, GermanyTests it Problems found, fixed voluntarilySep 8, 2022 · 4 inspections
Currenta GmbH & Co. OHGLeverkusen, GermanyTests it Problems found, fixed voluntarilyFeb 15, 2023 · 3 inspections
Micro-Macinazione SaMonteggio, SwitzerlandMills it Problems found, fixed voluntarilyNov 13, 2024 · 6 inspections
Packaging Coordinators, LLCPhiladelphia, PA, United StatesPackages it and labels it Problems found, fixed voluntarilyJan 31, 2025 · 6 inspections
Patheon Inc.Mississauga, CanadaTests it Problems found, fixed voluntarilyFeb 24, 2023 · 7 inspections

Product details

Generic drug
Oteseconazole: every company that makes it
Form
capsule, oral
Strength
150 mg
Approval
NDA NDA215888
On the market since
Jul 11, 2022
Package NDCs
74695-823-18
Official label
DailyMed (National Library of Medicine), updated Jan 8, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?